| Literature DB >> 1576236 |
B Alpha1, L Cox, N Crowther, P M Clark, C N Hales.
Abstract
Immunoenzymometric assays (IEMAs) for human insulin and intact proinsulin were developed using the amplification system developed by Johannsson et al. (Clin. Chim. Acta 148 (1985) 119-124) for the detection of the enzyme alkaline phosphatase. The detection limit of the assays was 0.8 pmol/l for proinsulin and 0.8 pmol/l for insulin whereas it was 1.8 pmol/l and 2.3 pmol/l respectively for the homologous immunoradiometric assays (IRMA). These assays are superior to immunoradiometric assays in terms of sensitivity, shelf-life of the labelled antibody and suitability for automation.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1576236 DOI: 10.1515/cclm.1992.30.1.27
Source DB: PubMed Journal: Eur J Clin Chem Clin Biochem ISSN: 0939-4974